InvestmentPitch Media Video Discusses Rakovina Therapeutics and its Presentation of Preclinical Data Supporting Potential Broad Anticancer Activity of kt-4000 Series at the American Association of Cancer Research Annual General Meeting
VANCOUVER, British Columbia, April 14, 2022 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSXV:RKV), a biopharmaceutical…